CD4 and tuberculosis: Increased memory CD4+ T cell responses were observed among individuals vaccinated with the M72/AS01E (Rodo et al., 2019), a candidate TB vaccine linked to ∼50% reduction in TB in a Phase 2B clinical trial (Tait et al., 2019).